DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Chalmers JD, Cipolla D, Thompson B. et al.
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies.
Eur Respir J 2020;
56 (04) 1-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.